Aramark, founded in 1936 and headquartered in Philadelphia, Pennsylvania, operates as a food service company providing facility management and workplace solutions... Show more
Aramark holds a top-two position in North America for food and facilities services (FSS), with a top-three ranking internationally in key markets, serving education, healthcare, business & industry, and sports & leisure sectors. This scale enables supply chain efficiencies and technology investments, such as AI-driven menu planning and dynamic pricing, enhancing margins. The FSS United States segment, comprising ~70% of revenue, benefits from stable contracts in education and healthcare, while international operations (~30%) drive diversification.
Competitively, Aramark trails Compass Group but leads in U.S. sports concessions and education dining. High retention (96.3%) and net new business growth reflect sticky, long-term contracts. Expansion into high-growth areas like AI data centers via Aramark Nexus differentiates it, targeting workforce hospitality for hyperscalers. Medium-term, outsourcing trends and margin recovery to pre-pandemic levels position Aramark favorably against fragmented local players.
Q2 FY2026 earnings on May 12 could reaffirm FY2026 guidance of $19.55-19.95 billion revenue (7-9% organic growth) and $2.18-2.28 adjusted EPS, with consensus at $2.22 EPS and $19.8 billion revenue. Beats here, especially on new wins or margins, may spur upgrades.
Ramp-up of major contracts like RWJ Barnabas Health (starting June 2026) and Aramark Nexus' hyperscaler deal signal revenue visibility. Analyst sentiment has turned optimistic, with 8 Buy/2 Hold ratings; recent hikes include UBS to $48 (April), Truist to $50 (Feb), and Citi to $51. Consensus target revisions upward reflect confidence in execution.
Dividend declaration (May 6) and leverage progress toward <3.0x underscore shareholder focus, potentially catalyzing buybacks.
Aramark's business model, with ~two-thirds profit-and-loss contracts, exposes it to food (~30% of costs), labor (~50%), and energy inflation, though fixed pricing and scale mitigate passthrough limits. Moderating inflation aids margins, targeting 30-40 bps expansion.
Sports/leisure sensitivity to consumer spending and events contrasts stable education/healthcare demand. Rising interest rates pressure leverage (currently ~3.25x), but FY2026 deleveraging supports flexibility. Geopolitical risks affect supply chains; technology shifts like AI data centers create tailwinds. Regulatory focus on wages and sustainability could raise costs but aligns with Aramark's ESG initiatives.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It leverages advanced machine learning to analyze historical patterns, technical indicators, and market data, enabling users to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across thousands of tradable instruments. The engine provides searchable prediction categories, historical performance context, and customizable alerts for real-time notifications. Ideal for active investors, it offers data-driven insights to inform timely decisions. Visit the Trend Prediction Engine to enhance your trading strategy today.
FY2026 guidance anchors expectations: 7-9% organic growth from new wins and volume, with adjusted operating income up 12-17% and leverage under 3.0x, enabling $500M+ free cash flow for dividends and repurchases. Consensus eyes $2.22 EPS, rising to $2.62 in FY2027, with revenue ~$20B then.
Structural drivers include market expansion in AI data centers, international growth (double-digit organic in UK/Chile/Spain), and cost efficiencies via tech/AI. Margin sustainability hinges on supply chain productivity; competitive threats from Compass/Sodexo loom in bids. Regulatory scrutiny on labor/ESG may elevate costs, but high retention and outsourcing trends favor incumbents. Capital priorities: deleveraging, then M&A/dividends. Analyst fair values cluster ~$47-48, implying measured optimism if execution holds.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a holding company with interests in food services and facilities management
Industry OfficeEquipmentSupplies
A.I.dvisor indicates that over the last year, ARMK has been loosely correlated with MSA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ARMK jumps, then MSA could also see price increases.
| Ticker / NAME | Correlation To ARMK | 1D Price Change % | ||
|---|---|---|---|---|
| ARMK | 100% | -0.48% | ||
| MSA - ARMK | 51% Loosely correlated | +0.25% | ||
| ARLO - ARMK | 50% Loosely correlated | +1.65% | ||
| EXPO - ARMK | 49% Loosely correlated | +0.81% | ||
| GHC - ARMK | 45% Loosely correlated | +1.55% | ||
| EFX - ARMK | 45% Loosely correlated | +2.59% | ||
More | ||||
| Ticker / NAME | Correlation To ARMK | 1D Price Change % |
|---|---|---|
| ARMK | 100% | -0.48% |
| Producer Manufacturing category (350 stocks) | 22% Poorly correlated | -0.22% |
| Office Equipment/Supplies category (45 stocks) | 17% Poorly correlated | -0.02% |
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ARMK declined for three days, in of 302 cases, the price declined further within the following month. The odds of a continued downward trend are .
The 10-day RSI Indicator for ARMK moved out of overbought territory on June 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 68 cases where ARMK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ARMK turned negative on June 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .
ARMK broke above its upper Bollinger Band on May 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on June 11, 2026. You may want to consider a long position or call options on ARMK as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARMK advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 283 cases where ARMK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.350) is normal, around the industry mean (16.052). P/E Ratio (40.500) is within average values for comparable stocks, (72.681). Projected Growth (PEG Ratio) (0.941) is also within normal values, averaging (1.546). Dividend Yield (0.009) settles around the average of (0.022) among similar stocks. P/S Ratio (0.745) is also within normal values, averaging (8.647).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARMK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.